Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
1.220
+0.030 (2.52%)
At close: Nov 22, 2024, 4:00 PM
1.214
-0.006 (-0.52%)
After-hours: Nov 22, 2024, 7:29 PM EST

Atossa Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-26.91-30.09-26.96-20.61-17.83-17.24
Upgrade
Depreciation & Amortization
0.030.020.010.020.050.05
Upgrade
Loss (Gain) From Sale of Assets
0-----
Upgrade
Loss (Gain) From Sale of Investments
1.712.99----
Upgrade
Stock-Based Compensation
2.044.626.795.273.028.84
Upgrade
Other Operating Activities
--0-3.30.01
Upgrade
Change in Accounts Payable
0.84-2.161.250.131.3-0.06
Upgrade
Change in Other Net Operating Assets
2.743.68-1.85-1.28-1.41-0.73
Upgrade
Operating Cash Flow
-19.55-20.94-20.76-16.47-11.57-9.13
Upgrade
Capital Expenditures
-0.02-0.01-0.03-0.01-0.01-0.01
Upgrade
Investment in Securities
---4.7---
Upgrade
Investing Cash Flow
-0.02-0.01-4.73-0.01-0.01-0.01
Upgrade
Issuance of Common Stock
0.3--113.8833.6211.34
Upgrade
Repurchase of Common Stock
--1.48--0.57-0.01-
Upgrade
Financing Cash Flow
0.3-1.48-113.338.5511.34
Upgrade
Net Cash Flow
-19.27-22.43-25.4996.8226.972.2
Upgrade
Free Cash Flow
-19.57-20.96-20.79-16.48-11.58-9.14
Upgrade
Free Cash Flow Per Share
-0.16-0.17-0.16-0.14-1.02-1.08
Upgrade
Levered Free Cash Flow
-12.76-11.76-10.54-21.726.82-4.1
Upgrade
Unlevered Free Cash Flow
-12.76-11.76-10.54-21.726.82-4.1
Upgrade
Change in Net Working Capital
-3.62-3.22014.17-12.892.2
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.